Summary & Overview
HCPCS J1736: Injection of Meloxicam (delova), 1 mg
HCPCS Level II code J1736 denotes a 1 mg injectable dose of meloxicam (delova). As an HCPCS Level II drug code, J1736 is used on medical claims to identify billing for the parenteral supply of meloxicam outside of facility drug bundles. Nationally, injectable NSAIDs like meloxicam are relevant for pain and inflammation management in outpatient procedural, infusion, and specialty clinic settings where oral administration is not feasible.
Key payers examined in this context include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find a concise review of how J1736 is used on service lines, where the drug is typically administered, and the clinical scenarios that prompt injectable meloxicam use. The publication also covers benchmark considerations for pricing and policy updates that affect coverage and reimbursement for HCPCS drug codes, plus coding practices that impact claim adjudication. Where input data was not provided, the publication notes that specific payer policies, modifier usage, associated taxonomies, ICD-10 pairings, and related codes are not available in the input.
Billing Code Overview
HCPCS Level II code J1736 represents an injection of meloxicam (delova), 1 mg. This code describes a parenteral pharmaceutical administration of the nonsteroidal anti-inflammatory drug meloxicam in a 1 mg unit.
-
Service type: Injectable medication administration (parenteral pharmacy service)
-
Typical site of service: Ambulatory infusion clinics, outpatient hospital departments, physician offices, and other outpatient settings where injectable medications are administered
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with chronic osteoarthritis of the knee presents to an outpatient infusion clinic for intra-articular analgesic therapy after inadequate symptom control with oral NSAIDs and topical measures. The provider orders a single-dose injectable NSAID formulation, J1736 (injection, meloxicam, 1 mg) to be administered intramuscularly or intra-articularly per manufacturer guidance. The clinical workflow includes verification of medication and dose, review of allergies and anticoagulation status, informed consent, site preparation using sterile technique, administration of the injection, observation for immediate adverse reactions for 15–30 minutes, documentation of lot number and expiration, and billing using the J1736 HCPCS Level II code. Typical sites of service are outpatient hospital-based infusion centers, physician offices, ambulatory surgery centers, and specialty clinics. Common clinical reasons for use include acute exacerbation of osteoarthritis pain, peri-procedural analgesia for minor joint procedures, or when oral therapy is contraindicated or not tolerated. The patient encounter includes pre-procedure assessment, the injection visit, and follow-up for pain response and adverse effects.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
59 | Distinct procedural service |